Trademark Overview
On Sunday, February 15, 2026, a trademark application was filed for OPENMEDICINE with the United States Patent and Trademark Office. The USPTO has given the OPENMEDICINE trademark a serial number of 99654254. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Sunday, February 15, 2026. This trademark is owned by Lantern Pharma Inc.. The OPENMEDICINE trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing online non-downloadable publications, namely, articles, reports, white papers, and newsletters, in the fields of artificial intelligence, systems biology, drug discovery, pharmaceutical research, cancer research, and research relating to other diseases and disorders; educational services, namely, providing webinars in the foregoing fields.
Scientific research and development in the field of pharmaceuticals; pharmaceutical research and development; medical and scientific research in the field of cancer; medical and scientific research in the fields of infectious diseases, metabolic and endocrine diseases, autoimmune and inflammatory diseases, neurological diseases, and cardiovascular diseases; drug discovery services; bioinformatics services; providing medical and scientific research information in the fields of pharmaceuticals, drug discovery, artificial intelligence, and systems biology; providing temporary use of non-downloadable software using artificial intelligence and systems biology for analyzing biomedical data to identify therapeutic targets, generate drug candidates, and predict drug efficacy and toxicity; providing a website featuring temporary use of non-downloadable software for the foregoing.
Providing a website featuring medical information in the field of cancer; providing a website featuring medical information in the field of diseases and medical conditions other than cancer.